for the bio-sciences sector
Oxford Optronix is proudly announces that it has been awarded a substantial grant from The Health Innovation Challenge Fund (a parallel funding partnership between the Wellcome Trust and the Department of Health) to fund clinical trials for a unique tissue oxygen monitoring device for detecting impending shock states and guiding therapy in the critically ill patient and those at high-risk. Further details can be found here.
WellBeing™ clinical trials commence
Happy New Year!
Ed Vaizey MP visits Oxford Optronix
Welcome to our new website!
Spring has sprung
Reflecting on 2016; looking forward to 2017
A little time Down Under…
Latest GelCount software update
Asia distributor workshop
Performance updates for HypoxyLab
Meet us at Genes & Cancer UK, Cambridge
Looking forward to a busy 2015
Oxford Optronix reaches new customers
Strategic tie-up with SciPro Inc., USA
Single-channel OxyFlo™ now shipping
GelCount™ software update
Reflections on 2013
Autumn conference round-up
Our 2013 Customer Survey results are out
Next-generation OxyLite™ and OxyFlo™ monitors